Search research articles
Contact Us
Filters
Showing results (551-560 of 807) with videos related to
Page
of 81
Sort By:
Biorxiv : the Preprint Server for Biology
|
September 21, 2023
A General Approach to Adjusting Genetic Studies for Assortative Mating
Marta Bilghese, Regina Manansala, Dhruva Jaishankar, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 16, 2016
Antimicrobial use and microbiological testing in district general hospital ICUs of the Veneto region of north-east Italy
P Benedetti, A M Sefton, M Menegozzo, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2002
Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives
Paul G Wyatt, Michael J Allen, Josie Chilcott, et al.
Genetics
|
December 15, 2019
Protection Against XY Gonadal Sex Reversal by a Variant Region on Mouse Chromosome 13
Catherine Livermore, Michelle Simon, Richard Reeves, et al.
BMC Infectious Diseases
|
January 7, 2022
AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications
Julia Notter, Salome N Seiffert, Maria Zimmermann-Kogadeeva, et al.
International Journal of Antimicrobial Agents
|
March 26, 2014
In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK
Katie L Hopkins, Shazad Mushtaq, Judith F Richardson, et al.
The Journal of Antimicrobial Chemotherapy
|
April 29, 2014
NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases
Anu Jain, Katie L Hopkins, Jane Turton, et al.
The Journal of Antimicrobial Chemotherapy
|
February 16, 2017
OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014
Jacqueline Findlay, Katie L Hopkins, Richard Loy, et al.
The Journal of Antimicrobial Chemotherapy
|
November 3, 2018
OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli
David M Livermore, Michaela Day, Paul Cleary, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2013
Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa
T W Felton, J Goodwin, L O'Connor, et al.
Page
of 81
Search research articles
Search
Showing results (551-560 of 807) with videos related to
Sort By:
Page
of 81
Biorxiv : the Preprint Server for Biology
|
September 21, 2023
A General Approach to Adjusting Genetic Studies for Assortative Mating
Marta Bilghese, Regina Manansala, Dhruva Jaishankar, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 16, 2016
Antimicrobial use and microbiological testing in district general hospital ICUs of the Veneto region of north-east Italy
P Benedetti, A M Sefton, M Menegozzo, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2002
Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives
Paul G Wyatt, Michael J Allen, Josie Chilcott, et al.
Genetics
|
December 15, 2019
Protection Against XY Gonadal Sex Reversal by a Variant Region on Mouse Chromosome 13
Catherine Livermore, Michelle Simon, Richard Reeves, et al.
BMC Infectious Diseases
|
January 7, 2022
AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications
Julia Notter, Salome N Seiffert, Maria Zimmermann-Kogadeeva, et al.
International Journal of Antimicrobial Agents
|
March 26, 2014
In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK
Katie L Hopkins, Shazad Mushtaq, Judith F Richardson, et al.
The Journal of Antimicrobial Chemotherapy
|
April 29, 2014
NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases
Anu Jain, Katie L Hopkins, Jane Turton, et al.
The Journal of Antimicrobial Chemotherapy
|
February 16, 2017
OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014
Jacqueline Findlay, Katie L Hopkins, Richard Loy, et al.
The Journal of Antimicrobial Chemotherapy
|
November 3, 2018
OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli
David M Livermore, Michaela Day, Paul Cleary, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2013
Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa
T W Felton, J Goodwin, L O'Connor, et al.
Page
of 81